scholarly journals Pulmonary vascular dysfunction in end-stage cystic fibrosis: role of NF- B and endothelin-1

2009 ◽  
Vol 34 (6) ◽  
pp. 1329-1337 ◽  
Author(s):  
P. Henno ◽  
C. Maurey ◽  
C. Danel ◽  
P. Bonnette ◽  
R. Souilamas ◽  
...  
2011 ◽  
Vol 300 (6) ◽  
pp. L831-L839 ◽  
Author(s):  
Priscilla Henno ◽  
Jean-François Boitiaux ◽  
Benoit Douvry ◽  
Aurélie Cazes ◽  
Marilyne Lévy ◽  
...  

Pulmonary vascular remodeling and dysfunction associated to tobacco smoking might pave the way for the subsequent development of pulmonary hypertension. Its prognosis is dreadful and its underlying mechanisms are so far largely unknown in humans. To assess the potential role of endothelin-1 and its receptors in smokers' pulmonary artery vasoactive properties. Endothelium-dependent vasodilation to ACh was assessed in pulmonary vascular rings from 34 smokers and compared with that of 10 nonsmokers. The effects of ET-A (BQ 123) or ET-B (BQ 788) blockers and that of an ET-B activator (sarafotoxin) were evaluated. Endothelin-1 was quantitated by ELISA. Expression of its receptors was quantitated by Western blotting. Smokers exhibited an impaired pulmonary endothelium-dependent vasodilation compared with nonsmokers ( P < 0.01). In the former group, 8 of 34 subjects exhibited a marked endothelial dysfunction (ED+) whereas 26 (ED−) ( P < 10−4) displayed a vasorelaxation to ACh that was comparable to that of nonsmokers. In ED+ subjects, ET-A was overexpressed ( P < 0.05) and inversely correlated ( P < 10−2) with the response to ACh. Sarafotoxin significantly improved vasodilation in all subjects ( P < 10−2). In conclusion, tobacco smoking is associated to an impaired pulmonary vasorelaxation at least partly mediated by an ET-1/ET-A-dependent dysfunction.


2004 ◽  
Vol 313 (1) ◽  
pp. 70-77 ◽  
Author(s):  
Adviye Ergul ◽  
Jeanette Schultz Johansen ◽  
Catherine Strømhaug ◽  
Alex K. Harris ◽  
Jimmie Hutchinson ◽  
...  

2020 ◽  
Vol 21 (8) ◽  
pp. 2806 ◽  
Author(s):  
Priscila Calle ◽  
Georgina Hotter

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease globally. The primary initiating mechanism in DN is hyperglycemia-induced vascular dysfunction, but its progression is due to different pathological mechanisms, including oxidative stress, inflammatory cells infiltration, inflammation and fibrosis. Macrophages (Mφ) accumulation in kidneys correlates strongly with serum creatinine, interstitial myofibroblast accumulation and interstitial fibrosis scores. However, whether or not Mφ polarization is involved in the progression of DN has not been adequately defined. The prevalence of the different phenotypes during the course of DN, the existence of hybrid phenotypes and the plasticity of these cells depending of the environment have led to inconclusive results. In the same sense the role of the different macrophage phenotype in fibrosis associated or not to DN warrants additional investigation into Mφ polarization and its role in fibrosis. Due to the association between fibrosis and the progressive decline of renal function in DN, and the role of the different phenotypes of Mφ in fibrosis, in this review we examine the role of macrophage phenotype control in DN and highlight the potential factors contributing to phenotype change and injury or repair in DN.


Thorax ◽  
2016 ◽  
Vol 72 (5) ◽  
pp. 460-471 ◽  
Author(s):  
Rachele Pandolfi ◽  
Bianca Barreira ◽  
Enrique Moreno ◽  
Victor Lara-Acedo ◽  
Daniel Morales-Cano ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document